Poseida was established in 2015 as a spinout from parent company Transposagen, an early leader in the development of gene engineering technologies, also led by our founding CEO, Eric Ostertag, M.D., Ph.D. Dr. Ostertag, the first graduate of the University of Pennsylvania’s gene therapy program, is a pioneer in the field of cell and gene therapies.